TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mcpherson’S Limited ( (AU:MCP) ) has provided an update.
McPherson’s Limited has announced that Mr. Ari Mervis will resume his role as Board Chairman from 1 February 2026, with Ms. Alison Cook continuing as a non-executive director and taking on the role of Chairman of the newly renamed Remuneration, People & Culture Committee. The company will also combine its Audit and Risk & Compliance Committees into a single Audit & Risk Committee, chaired by Ms. Helen Thornton, and establish a separate Nominations Committee led by Mr. Mervis. These changes are part of McPherson’s ongoing efforts to streamline its governance structure and enhance operational efficiency.
The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.
More about Mcpherson’S Limited
McPherson’s Limited is a prominent supplier of essential health, beauty, and wellness products in Australia, featuring iconic brands such as ‘Manicare’, ‘Lady Jayne’, ‘Dr. LeWinn’s’, ‘Swisspers’, and ‘Fusion Health’. The company focuses on expanding these brands through pharmacy, grocery, and e-commerce channels, and also offers a diverse range of products in segments like footwear, haircare, vitamins, supplements, fragrance, and nutrition. Headquartered in Sydney, McPherson’s is listed on the Australian Securities Exchange.
Average Trading Volume: 354,240
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$32.39M
For an in-depth examination of MCP stock, go to TipRanks’ Overview page.